Filament Health has developed a groundbreaking platform with the first-ever natural psychedelic drug candidates.
To date, the healing potential of natural psychedelic drugs has not been explored due to psychedelic prohibition and a lack of botanical extraction expertise.
We have developed technology which facilitates the production of stable, standardized formulations of any psychedelic species. These innovations have yielded patented methods to produce the world’s first pharmaceutical-grade, botanical psychedelic drug candidates, which are being studied in clinical trials around the world
Psychedelic Botanical Drug Processing Steps:
13 Filed 7 Granted
4 Filed
4 Filed
4 Filed
Filament’s IP is a combination of trade secrets and patented technologies which provide robust protection for our candidates, and leverage the known safety profiles of classical psychedelic substances. We secure patent protection for technologies used to extract, purify, stabilize, and standardize our products, as well as for the finished formulations of the drugs we manufacture.
Natural drug development provides an intellectual property advantage.
Unlike synthetically-derived drugs, botanical drugs are complex mixtures derived from natural sources. This complexity makes them difficult to replicate without knowledge of the exact manufacturing processes. As a result, our drug candidates have excellent protection beyond the patents we have been issued.
While there are many ways to create synthetic drugs, the methods to extract, purify, and standardize naturally-occurring psychedelic compounds are finite and therefore more readily protected with IP.
Filament's research and development facility is one of the first in the world to hold a Health Canada Dealer’s License and be GMP-compliant. These capabilities are required to manufacture and distribute drugs for human consumption in clinical trials or via authorized compassionate use.
OUR industry-leading facility allows us to:
- Propagate psychedelic plants and fungi
- Conduct genetic research
- Develop manufacturing technology
- Generate intellectual property
- Manufacture drug candidates for our own drug development as well as for distribution to drug developers, researchers, and other licensed parties
Filament’s research program includes all natural psychedelics: psilocybin, DMT, harmaline, mescaline, and more.
